Net Loss per Share - Anti-dilutive (Details) - shares	3 Months Ended	9 Months Ended
Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Potentially dilutive securities
Anti-dilutive common stock equivalent shares	6,719,806	3,833,871	6,719,806	3,833,871
Restricted Stock
Potentially dilutive securities
Anti-dilutive common stock equivalent shares	1,503,682	750,456	1,503,682	750,456
Stock options
Potentially dilutive securities
Anti-dilutive common stock equivalent shares	5,216,124	3,083,415	5,216,124	3,083,415

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration